Port A Cath
Port A Cath
PURPOSE:
To permit repeated access for short or long-term infusions of medications, blood products,
nutritional and other fluids, such as bolus injections, and venous blood sampling.
DEFINITIONS:
1. Implantable Portal Access Device: Totally implantable venous portal systems which allow
intravenous access for blood sampling and delivery of medications and fluids.
POLICY:
1. Physician’s Orders
A. Adult Patients
An order shall be written by the physician for the use of the device for blood
sampling, bolus injections, long or short-term infusions of drugs, fluids, nutritional
fluids, and blood products.
B. Pediatric Patients
All pediatric patients shall have separate, individualized physician orders that specify
the fluid amounts, (saline flush, heparin flush, medications) which will be
administered.
2. Patient/Family Education
Prior to insertion of the device, the patient/family/significant other shall be educated
regarding (education shall be documented in the medical record):
A. What the device is and how it works.
B. The purpose of the device in the patient’s plan of care.
C. Activity restrictions.
D. How to care for the site.
E. And given a copy of the Central Line Infection Prevention Education Sheet.
P81-1
P-81: Implantable Portal Access Device Page 2 of 14
Port-A-Cath, P.A.S. Port, Life Port
If the patient is to be discharged with an implantable portal access device in place, the
patient shall be given instructions on home care prior to discharge. These instructions shall
include at least:
A. Unless the device is accessed (needle or tubing attached), no special care is needed.
B. If the patient is to be discharged with an accessed portal device (needle and tubing
attached), the physician must be aware that the port is accessed on discharge and
why, and this information must be documented in the medical record. The site shall
be covered with a bio-occlusive (transparent impermeable) dressing and the patient
and significant other /family instructed to keep the dressing clean and dry and not to
attempt to cut, remove and/or otherwise alter the dressing or access in any way.
C. The site shall be regularly inspected for signs and symptoms of infection such as
redness, leakage, purulent drainage, bruising, or tenderness and the patient
instructed to watch for fever and generalized tiredness. Should any of these occur,
the physician/clinic should be notified immediately.
D. The physician should be consulted for instruction on any limitations of activity which
may cause problems with the port.
5. Hand Hygiene
Hands shall be washed with an antimicrobial soap before palpating, inserting, changing or
dressing any intravascular device.
P81-2
P-81: Implantable Portal Access Device Page 3 of 14
Port-A-Cath, P.A.S. Port, Life Port
Never exceed 40 psi pressure when delivering agents through the system.
8. Needle Usage
Only 20 - 22 gauge non coring needles shall be used to access the system utilizing the
following guidelines (Note: PowerLoc Safety Winged Infusion Needles shall be used
with the Power Port Implantable Port):
a. Ninety-degree needles shall be used for bolus or continuous infusions.
b. The needle shall be inserted perpendicular to the portal septum.
c. The needle shall never be tilted or rocked once the port has been entered.
d. Positive pressure shall be maintained while clamping the tubing prior to withdrawing
needle from the port to prevent reflux.
11. Blockage
Unusually high resistance encountered while administering any agent through the system
may indicate blockage. The physician shall be notified immediately when this occurs, and
P81-3
P-81: Implantable Portal Access Device Page 4 of 14
Port-A-Cath, P.A.S. Port, Life Port
b. The system shall be flushed with Heparinized Saline (100 units/ml) after each
use. When there are extended periods between injections, infusions, or blood
samplings the system shall be flushed using sterile technique with
5 cc Heparinized saline (using a 10 cc syringe) at least once every four weeks.
1. Sterile gloves
2. Chlorhexidine or Chloraprep prep stick
3. Sterile non-coring needles or PowerLoc Safety Winged Infusion Needles
4. IV administration set
5. Chemotherapy extension tubing with Luer lock
6. Normal saline flush solution
7. 5 cc (l00 units per cc) of heparinized saline solution (See 1B for pediatric patients).
8. Sterile dressing, either sterile gauze and tape, or a transparent impermeable dressing
9. 10 cc syringes
P81-4
P-81: Implantable Portal Access Device Page 5 of 14
Port-A-Cath, P.A.S. Port, Life Port
8. Removes gloves.
P81-5
P-81: Implantable Portal Access Device Page 6 of 14
Port-A-Cath, P.A.S. Port, Life Port
P81-6
P-81: Implantable Portal Access Device Page 7 of 14
Port-A-Cath, P.A.S. Port, Life Port
P81-7
P-81: Implantable Portal Access Device Page 8 of 14
Port-A-Cath, P.A.S. Port, Life Port
P81-8
P-81: Implantable Portal Access Device Page 9 of 14
Port-A-Cath, P.A.S. Port, Life Port
P81-9
P-81: Implantable Portal Access Device Page 10 of 14
Port-A-Cath, P.A.S. Port, Life Port
P81-10
P-81: Implantable Portal Access Device Page 11 of 14
Port-A-Cath, P.A.S. Port, Life Port
V. BLOOD SAMPLING
RESPONSIBLE ACTION RATIONALE
PARTY
MD, RN, RN 1. Explains procedure to patient.
Applicant
2. Follows procedure for accessing port using
sterile technique.
P81-11
P-81: Implantable Portal Access Device Page 12 of 14
Port-A-Cath, P.A.S. Port, Life Port
2. No special care to the site is needed unless an access (needle and tubing) is in place.
A bandage is not usually needed.
3. The site should be watched for signs of infection such as redness, leakage, purulent
drainage, bruising, and tenderness, and watch for fever, and generalized tiredness.
If any of these occur, call the unit/clinic telephone number provided at discharge.
4. If the site has a needle or tube in place at discharge, it should be covered with a special
bandage. The bandage and the access (needle and tubing) should be kept clean and dry and
no attempt should be made to cut, remove, and/or otherwise change the dressing, needle, or
tubing.
5. Should be flushed every 4-6 weeks; no appointment needed. Please come before 4:00 pm.
2. No special care to the site is needed unless an access (needle and tubing) is in place.
A bandage is not usually needed.
3. The site should be watched for signs of infection such as redness, leakage, purulent
drainage, bruising, and tenderness, and watch for fever, and generalized tiredness.
If any of these occur, call the unit telephone number provided at discharge.
4. If the site has a needle or tube in place at discharge, it should be covered with a special
bandage. The bandage and the access (needle and tubing) should be kept clean and dry and
no attempt should be made to cut, remove, and/or otherwise change the dressing, needle, or
tubing.
References:
P81-12
P-81: Implantable Portal Access Device Page 13 of 14
Port-A-Cath, P.A.S. Port, Life Port
Clinician Information Port-A-Cath and P.A.S. Port Implantable Access System - Pharmacia
Deltec.
P81-13
P-81: Implantable Portal Access Device Page 14 of 14
Port-A-Cath, P.A.S. Port, Life Port
________________________________________ _________________
Jamie Jett, MBA, RN Date
Administrative Nursing Director
Psychiatry, Coordinated Care and Professional Practice
________________________________________ _________________
Jean DiGrazia, MBA, RN Date
Assistant Hospital Administrator and CNO
Patient Care Services
P81-14